Detalhe da pesquisa
1.
The CAR-HEMATOTOX score identifies patients at high risk for hematological toxicity, infectious complications, and poor treatment outcomes following brexucabtagene autoleucel for relapsed or refractory MCL.
Am J Hematol
; 98(11): 1699-1710, 2023 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-37584447
2.
Impact of Pre-transplant Induction Therapy on Outcomes of Patients Who Undergo Autologous Stem Cell Transplantation for Mantle Cell Lymphoma in First Complete Remission.
Hematol Oncol Stem Cell Ther
; 16(2): 154-157, 2023 Jan 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-34425096
3.
Inferior Outcomes of EU Versus US Patients Treated With CD19 CAR-T for Relapsed/Refractory Large B-cell Lymphoma: Association With Differences in Tumor Burden, Systemic Inflammation, Bridging Therapy Utilization, and CAR-T Product Use.
Hemasphere
; 7(8): e907, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-37449196
4.
Severe hematotoxicity after CD19 CAR-T therapy is associated with suppressive immune dysregulation and limited CAR-T expansion.
Sci Adv
; 9(38): eadg3919, 2023 09 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-37738350
5.
The role of CAR-T cell therapy as second line in diffuse large B-cell lymphoma.
Ther Adv Hematol
; 13: 20406207221141511, 2022.
Artigo
em Inglês
| MEDLINE | ID: mdl-36505886
6.
Mindfulness in Adolescent and Young Adult (AYA) Patients Undergoing Hematopoietic Stem Cell Transplantation (HSCT): A Qualitative Study.
Cancers (Basel)
; 14(11)2022 Jun 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35681740
7.
Grade 3-4 cytokine release syndrome is associated with poor survival in haploidentical peripheral blood stem cell transplantation.
Leuk Lymphoma
; 62(8): 1982-1989, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-33627028
8.
High Ki67 proliferation index but not cell-of-origin subtypes is associated with shorter overall survival in diffuse large B-cell lymphoma.
Avicenna J Med
; 10(4): 241-248, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-33437697